SAN FRANCISCO (MarketWatch) -- Amgen Inc. after Wednesday's closing bell introduced Amgen Oncology Assistance, a financial assistance program that will include a cap on out-of-pocket co-payments for ...
THOUSAND OAKS, Calif., Oct. 6, 2025 /PRNewswire/ — Amgen (NASDAQ: AMGN) today announced the launch of AmgenNow, a new direct-to-patient program starting with Repatha ® (evolocumab). This follows ...
Amgen launched a direct-to-patient program Oct. 6 to offer its cholesterol medication Repatha at a reduced price. The AmgenNow program will provide Repatha for $239 per month — nearly 60% below the ...
Please provide your email address to receive an email when new articles are posted on . Evolocumab will be made available to eligible patients via a new direct-to-consumer program. The PCSK9 inhibitor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results